CONFERENCE SERIES: Biomarkers and Diagnostics
Recorded at: Leaders in Biobanking Congress
About this Product:
Part 1: Information Management: Conquering the Complexity of Biobanking
Biobanks provide the resource for researchers to increase our understanding of complex disease. Biosample resources come together through a complex chain of cooperation across collection, preservation, storage, retrieval, and research. The value of these biosamples lies not only in the samples themselves but with the metadata associated with each specimen. Information Management (IM) helps simplify data from inventory management to database integration through to data analysis. Learn from biobank managers and IT professionals as they share their experience of conquering the complexity of biobanking.
Part 2: Lab Automation: Hands-On through Hands-Off Biobanking
How Do You Invest in the Future?
A well managed biobank is an investment that pays dividends. Biobanks create repositories of biological specimens for further biomolecular investigations. The sample types collected, preserved, stored, and distributed can be extremely diverse. Thus, laboratory automation is a critical component for handling ever increasing demands.
About this Product:
3 Presentations
116 Slides
Over 81 Minutes
Individual: $345
Site License: $1380
Agenda At A Glance:
Part 1:
QC/QM of Biosamples in Cancer Biobanks: LIMS
Pedro Rondot Radío, M.D., Executive Director, Public National Oncologic Serum Biobank, University of Buenos Aires
Biography: Pedro Rondot Radio is the Executive Director of the Public Oncologic Serum Biobank at the Institute of Oncology at the University of Buenos Aires. He received his M.D. at the National University of Rosario. Before his position at the institute of Oncology, he worked as a trainer of biobank techniques at the solid tumor bank at the National Pediatric Hospital of Buenos Aires. He is involved in a range of activities relating to hemostasis and thrombosis, including patients with bleeding disorders as well as control and treatment of patients with DIC and HIT in the ICU.
Building a Flexible Informatics Guided Workflow to Improve the Quality of Biobanking Operations
Rao Mulpuri, Ph.D., Director, Center for Translational Research, CIRI, Catholic Health Initiatives
Biography: Rao Mulpuri serves as a Director of Scientific Operations at the Catholic Health Initiatives (CHI's) Center for Translational Research, and provides leadership to facilitate the advancement, commercialization and integration of personalized medicine. Rao has an MBA (Honors), a Ph.D. in life sciences and has published 36 scientific publications in peer-reviewed scientific journals, and named as an inventor on 14 patents. Rao is a strategic visionary leader with a unique blend of entrepreneurial vision and business acumen, and his specialties include developing business/commercial strategies and launching new ventures (start-ups), leading business units during both the start-up and corporate transformation (Merger and Acquisition) phases, management of scientific/technical operations (Genomics, Biomarker Discovery and Validation, Personalized Medicine), quality and regulatory affairs, and technology evaluation for investments/new ventures. Prior to joining the CTR, Rao served as the Site Head of a Biomarker discovery and Clinical testing facility of Beckman Coulter Genomics (formerly Cogenics).
Part 2:
Challenges of an Automated Biobank: From Sample Processing to Storage
Ellis Gitlin, Director of Sales, Hamilton Storage Technologies
Biography: Ellis Gitlin is the Director of Sales at Hamilton Storage Technologies. He received his M.S. in Biology at Seton Hall University. Before his position at Hamilton, he worked as the Business Development Manager of Life Sciences at GE Healthcare, where he was responsible for Mass Spectrometry and Capillary Chromatography Sales.
About the Conference:
Today, biospecimen collections are used by multiple research groups for varying research aims from basic research through clinical trials. A well managed biobank is a critical prerequisite for high-quality biological research. Proper collection, processing, storage, and tracking of biospecimens are critical components allowing researchers to better link molecular and clinical information. Thus, by necessity, biobanking is both a science and a business. Cambridge Healthtech Institute’s Third International Leaders in Biobanking Congress addresses both the business and science angles of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best tactics for effective use of biospecimens within today’s cutting edge research.